COMPANY PROFILE · UPDATED 01 AUG 2026

4D Molecular Therapeutics

4d Molecular Therapeutics, LLC operates as a biotechnology company. The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions. 4d Molecular Therapeutics serves customers in the…

4dmoleculartherapeutics.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2013
Headcount: 160
Open roles: 11
Last raised: Post Ipo Equity · Sign in to view

TECH STACK

How 4D Molecular Therapeutics builds

LEADERSHIP

Founders & key people

David Kirn

CEO at 4D Molecular Therapeutics

4D Molecular TherapeuticsIGNITE ImmunotherapyUniversity of California BerkeleyJohnson & JohnsonCelgeneJennerexUniversity of California BerkeleyHaas School of Business - UC BerkeleyUCSFHarvard Medical School

Theresa Janke

Management at 4D Molecular Therapeutics

4D Molecular TherapeuticsIGNITE ImmunotherapySillaJenCelgeneJennerex Biotherapeutics UlcAbbott VascularUniversity of California Santa Barbara

David Schaffer

Researcher ORCID ID = 0000-0002-9625-0121

QB3ValitorUniversity of California BerkeleyAxent BiosciencesGenEditBakar LabsMassachusetts Institute of Technology (MIT)Stanford UniversityRidge High School

OPEN ROLES

Hiring at 4D Molecular Therapeutics

View all 11 open roles →

FUNDING

Capital raised

Total raised

$702,499,995

Investors

Amzak Health InvestorsArrowMark Colorado HoldingsBVF PartnersBerkeley Catalyst FundCasdin CapitalChiesi VenturesCureDuchenne VenturesCystic Fibrosis FoundationJanus CapitalLongevity Vision FundMirae AssetOctagon Capital AdvisorsPappas CapitalPerceptive AdvisorsPfizer Venture InvestmentsQUAD Investment ManagementRidgeback Capital ManagementViking Global Investors

Funding rounds

Post Ipo Equity
$100MNov 6, 2025
Post Ipo Equity
$7.5MOct 13, 2025
Post Ipo Equity
$300MFeb 5, 2024
Post Ipo Equity
$120MMay 3, 2023
Series C
Viking Global Investors, Cystic Fibrosis Foundation, Ridgeback Capital Management, Amzak Health Investors, ArrowMark Colorado Holdings, Casdin Capital, Perceptive Advisors, Berkeley Catalyst Fund, Pfizer Venture Investments, QUAD Investment Management, Chiesi Ventures, Pappas Capital, BVF Partners, Mirae Asset, Longevity Vision Fund, Octagon Capital Advisors
$75MJun 15, 2020
IPO
UndisclosedJan 1, 2020
Series B
Viking Global Investors, CureDuchenne Ventures, Ridgeback Capital Management, Mirae Asset, Perceptive Advisors, ArrowMark Colorado Holdings, Janus Capital, Pappas Capital, Pfizer Venture Investments, Berkeley Catalyst Fund, Chiesi Ventures, BVF Partners
$90MSep 4, 2018
Series Unknown
Cystic Fibrosis Foundation
$3MSep 18, 2017
Series Unknown
$7MAug 12, 2015

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Collections

Has Woman Founder

Tech Stack

Mysql Php Wordpress Microsoft Azure

LOCATIONS

Where they work

4D Molecular Therapeutics offices

Loading map…

Emeryville, CA5858 Horton Street #455